摘要
目的对比分别应用奥曲肽与垂体后叶素对肝硬化上消化道出血患者进行治疗可以取得的临床疗效。方法选取该院近来3年收治的肝硬化上消化道出血患者200例,随机将其分为A、B两组,对比A、B两组患者的临床疗效。结果 A组患者的总有效率为99%,B组患者的总有效率为70%,A组临床疗效显著优于B组,此外,A组患者不良反应发生率为5%,B组患者的不良反应发生率为52%,A组明显低于B组,两者的差异有统计学意义(P<0.05)。结论应用奥曲肽对肝硬化上消化道出血患者进行治疗,其临床疗效明显优于垂体后叶素,并且不良反应出现几率也很低,值得各大医院推广应用。
Objective To compare the clinical curative effect between octreotide and pituitrin on liver cirrhosis patients with upper gastrointestinal bleeding. Methods 200 cases of liver cirrhosis patients with upper gastrointestinal hemorrhage admitted in our hospital in recent 3 years were selected and randomly divided into A group and B group, the clinical efficacy of the two groups was compared. Results The total effective rate of the patients in A group was 99%, and that of the patients in B group was 70%, the clinical curative effect of A group was higher than that of B group. In addition, the incidence of adverse reactions of the patients in A group was 5%, and that of B group was 52%, the incidence of adverse reactions of A group was significantly lower than that of B group, the difference between them was statistical significant （P〈0.05）. Conclusion For patients with cirrhosis and upper gastrointestinal hemorrhage, the clinical curative effect of octreotide is obviously better than that of pituitrin with lower incidence of adverse reactions, which is worthy of popularization and application in hospitals.
出处
《中外医疗》
2014年第19期21-22,共2页
China & Foreign Medical Treatment
关键词
奥曲肽
垂体后叶素
肝硬化上消化道出血
临床疗效对比
Octreotide
Pituitrin
Cirrhosis with upper gastrointestinal hemorrhage
Comparison of clinical efficacy
